Kisqali (200 Mg Dose)
Kisqali (200 MG Dose) 21 Tablets Therapy Pack
¿Qué es Kisqali (200 Mg Dose)?
Kisqali (ribociclib) es un inhibidor selectivo de las cinasas dependientes de ciclina 4 y 6 (CDK4/6), que son cruciales en la proliferación de las células cancerígenas. Está indicado para el tratamiento del cáncer de mama avanzado o metastásico positivo a receptores hormonales y negativo al receptor 2 del factor de crecimiento epidérmico humano, típicamente en combinación con un inhibidor de la aromatasa. Administrado en una dosis de 200 mg, Kisqali se toma por vía oral y desempeña un papel crítico en la interrupción de la división y crecimiento celular en células específicas de cáncer de mama.Side Effects
- Dark urine or pale stools, nausea, vomiting, loss of appetite, stomach pain, yellow skin or eyes
- Fainting, dizziness, lightheadedness
- Blistering, peeling, red skin rash
Warnings
- Talk with your doctor before using this medicine if you plan to have children. Some men who use this medicine have become infertile (unable to have children).
- Oral routeIt is not safe to take this medicine during pregnancy. It could harm an unborn baby. Tell your doctor right away if you become pregnant. If you are a woman who can bear children, your doctor may give you a pregnancy test before you start using this medicine to make sure you are not pregnant. Women should use an effective form of birth control during treatment and for at least 3 weeks after the last dose.
- This medicine may cause the following problems:Interstitial lung disease or pneumonitis (can be life-threatening)Serious skin reactions, including Stevens-Johnson syndrome, toxic epidermal necrolysis, or drug reaction with eosinophilia and systemic symptoms (DRESS)Heart rhythm problem, including QT prolongationLiver problems
- Oral routeMedicines used to treat cancer are very strong and can have many side effects. Before receiving this medicine, make sure you understand all the risks and benefits. It is important for you to work closely with your doctor during your treatment.
- Your doctor will do lab tests at regular visits to check on the effects of this medicine. Keep all appointments.
Prescription savings · ·
¿Qué es Kisqali (200 Mg Dose) ?
Kisqali (ribociclib) es un inhibidor selectivo de las cinasas dependientes de ciclina 4 y 6 (CDK4/6), que son cruciales en la proliferación de las células cancerígenas. Está indicado para el tratamiento del cáncer de mama avanzado o metastásico positivo a receptores hormonales y negativo al receptor 2 del factor de crecimiento epidérmico humano, típicamente en combinación con un inhibidor de la aromatasa. Administrado en una dosis de 200 mg, Kisqali se toma por vía oral y desempeña un papel crítico en la interrupción de la división y crecimiento celular en células específicas de cáncer de mama.Kisqali (200 Mg Dose) Cupones y Precios - Rx.com
Kisqali (200 MG Dose) 21 Tablets Therapy Pack
Browse more medications: starting with K · full A-Z directory · by condition · common drugs
Medical disclaimer: This information is provided for general educational purposes only and is not medical advice. It is not a substitute for professional diagnosis or treatment. Always consult a licensed physician, pharmacist, or other qualified healthcare provider before starting, stopping, or changing any medication or treatment. Never disregard professional medical advice or delay seeking it because of something you read here. If you think you may have a medical emergency, call your doctor or 911 immediately.